Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. - Ridker PM; Rifai N; Clearfield M; Downs JR; Weis SE; Miles JS; Gotto AM Jr.; Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators; Ridker, P M; Rifai, N; Clearfield, M; Downs, J R; et al. (New England Journal of Medicine, 2001)